Living with AIP: Diet, Lifestyle, and Your Care Team
At a Glance
Successfully managing Acute Intermittent Porphyria (AIP) requires strict attention to your diet and lifestyle. The most crucial steps are eating regular meals to avoid fasting and verifying that every medication you take is safe, which helps prevent severe and potentially life-threatening attacks.
Living with Acute Intermittent Porphyria (AIP) requires a shift in how you view your body—from a passive observer to an active manager of your metabolism. Because your condition is rare, you will often find yourself as the most informed person in the room. By mastering your diet, verifying every medication, and building a knowledgeable care team, you can significantly reduce the risk of attacks and live a full life.
The Porphyria Diet: Fueling Stability
In AIP, food is more than just nutrition; it is a metabolic stabilizer. A healthy, well-balanced diet is essential. While past guidelines suggested a massive daily carbohydrate intake, we now know that such extremes can lead to obesity or diabetes. The most critical rule for daily life is to avoid fasting and eat regular meals [1]. Carbohydrates help suppress the ALAS1 enzyme, the “worker” that triggers the buildup of toxic precursors [1].
- Never Fast: Fasting, skipping meals, or extreme low-calorie dieting are some of the most dangerous triggers for an attack [2][3].
- Frequent Fueling: Instead of three large meals, many patients find success with smaller, more frequent meals throughout the day to keep their energy levels stable.
- Emergency Carbohydrates: Carbohydrate loading—a temporary surge of carbs—is reserved only as a short-term intervention. If you feel the early signs of an attack (like mild abdominal pain or anxiety), increasing your carbohydrate intake immediately may help prevent it from becoming severe [4][5].
Verifying Medication Safety
One of the most critical daily tasks for an AIP patient is checking the safety of any medication, supplement, or herb. Many common drugs—including some antibiotics, sedatives, and hormones—are porphyrinogenic, meaning they can trigger a life-threatening crisis [2][6].
How to Check a Drug:
- Use a Database: Bookmark official resources like drugs-porphyria.org or the American Porphyria Foundation database [6][7].
- Look for “Safe” vs. “Unsafe”: These databases use a color-coded system to tell you if a drug is safe, probably safe, or strictly forbidden.
- Check Every Time: Even if you have taken a drug before, check it again. Formulations and safety data can change.
- Consult Your Specialist: If a drug is listed as “unsafe” but is medically necessary, your specialist must be involved to weigh the risks and potentially provide “cover” with hemin [8].
Building Your Care Team
Because AIP is a multi-system disorder, you need a team of specialists who talk to one another. Your team should ideally include:
- The Lead Specialist: Usually a Hepatologist (liver doctor) or a Hematologist (blood doctor) with specific experience in porphyria [9].
- Neurologist or Pain Management Specialist: Since attacks cause severe nerve damage and intense pain, a specialist who can manage these symptoms safely is essential.
- Genetic Counselor: To help you understand your mutation and manage the testing of your family members [10].
- Registered Dietitian: To help you design a balanced meal plan that avoids fasting.
- Nephrologist: A kidney doctor to monitor your long-term kidney health, especially if you have high blood pressure [11].
- Primary Care Provider (PCP): Your local “anchor” who manages your overall health and coordinates with the specialists.
Practical Tools for Self-Monitoring
- Medical Alert Jewelry: Wear a bracelet or necklace that says “Acute Intermittent Porphyria” and lists “NO Barbiturates / NO Sulfonamides.”
- Symptom Diary: Keep a log of your pain, energy levels, and menstrual cycle (for women) to identify your personal patterns and triggers.
- What to Bring to the ER Checklist:
- Your signed Emergency Letter detailing the need for IV hemin and high-dose glucose, as many ER doctors may not know the proper protocol [1][12].
- A printed list of your safe/unsafe medications.
- A copy of your biochemical and genetic diagnostic test results.
- Contact information for your primary porphyria specialist.
Common questions in this guide
Why is fasting dangerous for someone with Acute Intermittent Porphyria?
How can I safely check if a medication will trigger an AIP attack?
What should I do if I feel the early signs of an AIP attack?
What doctors should be on my AIP care team?
What information should I bring to the ER during an AIP emergency?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.How many patients with acute porphyria have you personally treated or managed?
- 2.Are you comfortable prescribing and managing hemin (Panhematin) or Givosiran (Givlaari)?
- 3.Which specific porphyria specialist or center of excellence do you consult with for complex cases?
- 4.How will we coordinate my annual liver ultrasound and kidney function tests?
- 5.In an emergency, will you be available to speak directly with the ER physicians to ensure I receive the correct treatment (IV hemin/glucose)?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (12)
- 1
Acute Hepatic Porphyrias: Review and Recent Progress.
Wang B, Rudnick S, Cengia B, Bonkovsky HL
Hepatology communications 2019; (3(2)):193-206 doi:10.1002/hep4.1297.
PMID: 30766957 - 2
Identification and characterization of 40 novel hydroxymethylbilane synthase mutations that cause acute intermittent porphyria.
Chen B, Solis-Villa C, Erwin AL, et al.
Journal of inherited metabolic disease 2019; (42(1)):186-194 doi:10.1002/jimd.12040.
PMID: 30740734 - 3
Acute intermittent porphyria (AIP) in a patient with celiac disease.
Nunnemann S, Uibel C, Budig P, Mäurer M
Neurological research and practice 2020; (2()):2 doi:10.1186/s42466-020-0049-6.
PMID: 33324908 - 4
Protocol For Patients With Suspected Acute Porphyria.
Castelbón Fernández FJ, Solares Fernandez I, Arranz Canales E, et al.
Revista clinica espanola 2020; (220(9)):592-596 doi:10.1016/j.rce.2019.10.012.
PMID: 32143835 - 5
Acute intermittent porphyria presenting with posterior reversible encephalopathy syndrome and lateralized periodic discharges plus fast activity on EEG.
Silveira DC, Bashir M, Daniel J, et al.
Epilepsy & behavior case reports 2016; (6()):58-60 doi:10.1016/j.ebcr.2016.08.004.
PMID: 27660746 - 6
Acute Porphyrias.
Besur S, Schmeltzer P, Bonkovsky HL
The Journal of emergency medicine 2015; (49(3)):305-12.
PMID: 26159905 - 7
Update on the Porphyrias.
Dickey AK, Leaf RK, Balwani M
Annual review of medicine 2024; (75()):321-335 doi:10.1146/annurev-med-042921-123602.
PMID: 37540847 - 8
Liver transplantation and primary liver cancer in porphyria.
Lissing M, Wang B, Wahlin S
Liver international : official journal of the International Association for the Study of the Liver 2025; (45(3)):e15894 doi:10.1111/liv.15894.
PMID: 38456621 - 9
Acute hepatic porphyrias: Recommendations for diagnosis and management with real-world examples.
Moghe A, Dickey A, Erwin A, et al.
Molecular genetics and metabolism 2023; (140(3)):107670 doi:10.1016/j.ymgme.2023.107670.
PMID: 37542766 - 10
Self-efficacy and self-management strategies in acute intermittent porphyria.
Hammersland MH, Aarsand AK, Sandberg S, Andersen J
BMC health services research 2019; (19(1)):444 doi:10.1186/s12913-019-4285-9.
PMID: 31269991 - 11
Risk for incident comorbidities, nonhepatic cancer and mortality in acute hepatic porphyria: A matched cohort study in 1244 individuals.
Lissing M, Vassiliou D, Floderus Y, et al.
Journal of inherited metabolic disease 2023; (46(2)):286-299 doi:10.1002/jimd.12583.
PMID: 36546345 - 12
Development and validation of diagnostic algorithms for the laboratory diagnosis of porphyrias.
Lefever S, Peersman N, Meersseman W, et al.
Journal of inherited metabolic disease 2022; (45(6)):1151-1162 doi:10.1002/jimd.12545.
PMID: 36053909
This guide on managing Acute Intermittent Porphyria is for educational purposes only and does not replace professional medical advice. Always consult your porphyria specialist before changing your diet, trying new treatments, or taking new medications.
Get notified when new evidence is published on HMBS-related hepatic porphyria.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.